ZAPONEX

This brand name is authorized in Netherlands, United Kingdom

Active ingredients

The drug ZAPONEX contains one active pharmaceutical ingredient (API):

1 Clozapine UNII J60AR2IKIC - CLOZAPINE

Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties. Read about Clozapine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZAPONEX Orodispersible tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AH02	Clozapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 101219, 101222, 376873, 376876, 376880, 376884, 376889, 88391, 88408
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 201413, 201421, 201448, 201456, 201480